• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PATCH 研究:成骨不全症患者听力损失的流行情况和治疗选择:一项丹麦全国基于登记的队列研究。

The PATCH study: Prevalence of Hearing Loss During Ageing and Treatment Choices in Osteogenesis Imperfecta: A Danish Nationwide Register-Based Cohort Study.

机构信息

Department of Endocrinology, Bone and Mineral Unit, Odense University Hospital, Kløvervænget 6, 5 Floor, 5000, Odense C, Denmark.

Department of ORL-Head and Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark.

出版信息

Calcif Tissue Int. 2024 Sep;115(3):260-268. doi: 10.1007/s00223-024-01253-w. Epub 2024 Jul 16.

DOI:10.1007/s00223-024-01253-w
PMID:39012488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11333522/
Abstract

Osteogenesis imperfecta (OI) is a group of rare hereditary collagen disorders. Hearing loss (HL) is a known complication linked to changes in the bones of the middle ear seen in OI. We aimed to determine the prevalence, age at debut, incidence, and risk of HL, surgery on bones of the middle ear, and use of hearing aids. A Danish nationwide, register-based cohort study. Data were extracted from the Danish National Patient register. Anyone with an OI diagnosis between January 1st 1977 and December 31st 2018, matched 1:5 with a reference population (Ref.Pop) on birthyear and sex, were included. 864 persons (487 women) with OI were included in the study and 4276 (2330 women) in the Ref.Pop. The sub-hazard ratio (SHR) for any HL was 4.56 [95% CI 3.64-5.71], with a prevalence of 17.0% and 4.0% in the OI cohort and Ref.Pop. Median age at debut was 42 and 58 years, respectively. The risk of otosclerosis and/or surgery was higher in the OI cohort (SHR 22.51 [95% CI 12.62-40.14]), with a median age at debut of 43 and 32 years in the OI cohort and Ref.Pop, respectively. Hearing aid use was more frequent in the OI cohort (SHR 4.16 [95% CI 3.21-5.40]) than in the Ref.Pop. The median age at debut was 45 and 60 years in the OI cohort and Ref.Pop, respectively. Persons with OI have a higher risk and prevalence of HL, hearing aids, and surgery, debuting younger, and prevalence increases with age.

摘要

成骨不全症(OI)是一组罕见的遗传性胶原疾病。听力损失(HL)是一种已知的并发症,与 OI 中中耳骨骼的变化有关。我们旨在确定 HL、中耳骨骼手术和助听器使用的患病率、首次发病年龄、发病率和风险。一项丹麦全国范围内基于登记的队列研究。数据从丹麦国家患者登记处提取。任何在 1977 年 1 月 1 日至 2018 年 12 月 31 日期间患有 OI 诊断的人,按出生年份和性别与参考人群(Ref.Pop)匹配 1:5,均被纳入研究。研究包括 864 名(487 名女性)OI 患者和 4276 名(2330 名女性)Ref.Pop。任何 HL 的亚危险比(SHR)为 4.56 [95%CI 3.64-5.71],OI 队列和 Ref.Pop 的患病率分别为 17.0%和 4.0%。首次发病年龄的中位数分别为 42 岁和 58 岁。OI 队列的耳硬化症和/或手术风险更高(SHR 22.51 [95%CI 12.62-40.14]),首次发病年龄的中位数分别为 43 岁和 32 岁。OI 队列的助听器使用率高于 Ref.Pop(SHR 4.16 [95%CI 3.21-5.40])。OI 队列和 Ref.Pop 的首次发病年龄的中位数分别为 45 岁和 60 岁。OI 患者的 HL、助听器和手术的风险和患病率更高,首次发病年龄更早,患病率随年龄增长而增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc91/11333522/6fab8778a266/223_2024_1253_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc91/11333522/5d2a7307a29a/223_2024_1253_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc91/11333522/783f9978e870/223_2024_1253_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc91/11333522/6fab8778a266/223_2024_1253_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc91/11333522/5d2a7307a29a/223_2024_1253_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc91/11333522/783f9978e870/223_2024_1253_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc91/11333522/6fab8778a266/223_2024_1253_Fig3_HTML.jpg

相似文献

1
The PATCH study: Prevalence of Hearing Loss During Ageing and Treatment Choices in Osteogenesis Imperfecta: A Danish Nationwide Register-Based Cohort Study.PATCH 研究:成骨不全症患者听力损失的流行情况和治疗选择:一项丹麦全国基于登记的队列研究。
Calcif Tissue Int. 2024 Sep;115(3):260-268. doi: 10.1007/s00223-024-01253-w. Epub 2024 Jul 16.
2
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.丹麦成骨不全患者的死亡率和发病率。
Dan Med J. 2018 Apr;65(4).
3
Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta: A Nationwide Register-Based Cohort Study.成骨不全患者的骨折发生率及骨折部位:一项基于全国登记的队列研究。
J Bone Miner Res. 2017 Jan;32(1):125-134. doi: 10.1002/jbmr.2920. Epub 2016 Aug 29.
4
Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register-Based Nationwide Cohort Study.成骨不全患者的死亡率和死因:一项基于全国登记的队列研究
J Bone Miner Res. 2016 Dec;31(12):2159-2166. doi: 10.1002/jbmr.2895. Epub 2016 Jul 18.
5
Risk of Gastrointestinal Diseases in Osteogenesis Imperfecta: A Nationwide, Register-Based Cohort Study.成骨不全症患者患胃肠道疾病的风险:一项基于全国登记的队列研究
Calcif Tissue Int. 2025 Jan 3;116(1):15. doi: 10.1007/s00223-024-01311-3.
6
Cardiovascular disease in patients with osteogenesis imperfecta - a nationwide, register-based cohort study.成骨不全患者的心血管疾病——一项基于全国登记数据库的队列研究
Int J Cardiol. 2016 Dec 15;225:250-257. doi: 10.1016/j.ijcard.2016.09.107. Epub 2016 Sep 30.
7
Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults.成骨不全症与牙齿、眼睛和耳朵:成年人的非骨骼表型研究。
Osteoporos Int. 2018 Dec;29(12):2781-2789. doi: 10.1007/s00198-018-4663-x. Epub 2018 Aug 24.
8
Risk of Pulmonary Diseases in Osteogenesis Imperfecta in Denmark: A Register-Based Cohort Study.丹麦成骨不全症患者患肺部疾病的风险:一项基于登记的队列研究。
Chest. 2025 Mar;167(3):806-817. doi: 10.1016/j.chest.2024.09.004. Epub 2024 Sep 17.
9
Risk of eye diseases in osteogenesis imperfecta - A nationwide, register-based cohort study.成骨不全症相关眼病风险——一项全国范围内基于登记的队列研究。
Bone. 2022 Jan;154:116249. doi: 10.1016/j.bone.2021.116249. Epub 2021 Oct 30.
10
Osteoarthritis in osteogenesis imperfecta: A nationwide register-based cohort study.成骨不全症相关骨关节炎:一项全国基于登记的队列研究。
Bone. 2022 Jan;154:116222. doi: 10.1016/j.bone.2021.116222. Epub 2021 Sep 28.

引用本文的文献

1
Hearing loss in Chinese osteogenesis imperfecta patients.中国成骨不全症患者的听力损失
Eur Arch Otorhinolaryngol. 2025 Apr 12. doi: 10.1007/s00405-025-09390-0.

本文引用的文献

1
Brazilian Society of Otology task force - Otosclerosis: evaluation and treatment.巴西耳科学学会工作组 - 耳硬化症:评估与治疗。
Braz J Otorhinolaryngol. 2023 Sep-Oct;89(5):101303. doi: 10.1016/j.bjorl.2023.101303. Epub 2023 Aug 17.
2
Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA-1273: A Danish Population-Based Cohort Study.接种 BNT162b2 或 mRNA-1273 后突发感觉神经性听力损失:一项丹麦基于人群的队列研究。
Otolaryngol Head Neck Surg. 2023 Dec;169(6):1472-1480. doi: 10.1002/ohn.394. Epub 2023 Jun 8.
3
Risk of eye diseases in osteogenesis imperfecta - A nationwide, register-based cohort study.
成骨不全症相关眼病风险——一项全国范围内基于登记的队列研究。
Bone. 2022 Jan;154:116249. doi: 10.1016/j.bone.2021.116249. Epub 2021 Oct 30.
4
Current Overview of Osteogenesis Imperfecta.成骨不全症概述。
Medicina (Kaunas). 2021 May 10;57(5):464. doi: 10.3390/medicina57050464.
5
Observed Frequency and Characteristics of Hearing Loss in Osteogenesis Imperfecta.成骨不全症患者听力损失的观察频率和特征。
Rev Med Chil. 2020 Dec;148(12):1781-1786. doi: 10.4067/S0034-98872020001201781.
6
Bone properties in osteogenesis imperfecta: what can we learn from a bone biopsy beyond histology?成骨不全症中的骨骼特性:除了组织学之外,骨活检还能让我们了解什么?
Wien Med Wochenschr. 2021 Apr;171(5-6):111-119. doi: 10.1007/s10354-021-00818-w. Epub 2021 Feb 22.
7
Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis.骨脆弱机制:从成骨不全症到继发性骨质疏松症。
Int J Mol Sci. 2021 Jan 10;22(2):625. doi: 10.3390/ijms22020625.
8
Stapes surgery in osteogenesis imperfecta: retrospective analysis of 18 operated ears.耳硬化症镫骨手术:18 例手术耳的回顾性分析。
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4697-4705. doi: 10.1007/s00405-020-06581-9. Epub 2021 Jan 12.
9
Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study.北美成骨不全症个体的听力损失:一项多中心研究的结果。
Am J Med Genet A. 2020 Apr;182(4):697-704. doi: 10.1002/ajmg.a.61464. Epub 2019 Dec 26.
10
Hearing impairment and osteogenesis imperfecta: Literature review.听力障碍与成骨不全症:文献综述。
Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Oct;136(5):379-383. doi: 10.1016/j.anorl.2019.05.004. Epub 2019 Jun 13.